Ajooni Biotech Limited (NSE:AJOONI)

Ajooni Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	3.74	4.19	68.3	4.28	3.09	0.57
Short-Term Investments	-	-	4.4	0.02	3.26	1.18
Cash & Short-Term Investments	3.74	4.19	72.7	4.3	6.35	1.75
Cash Growth	-97.63%	-94.24%	1589.22%	-32.25%	262.20%	-56.61%
Accounts Receivable	165.61	178.34	162.16	129.59	205.51	138.4
Other Receivables	-	7	5.52	0.79	3.24	0.12
Receivables	302.27	326.83	167.68	130.38	208.75	138.52
Inventory	418.1	394.55	239.87	153.67	69.94	58.82
Prepaid Expenses	-	-	1.37	3.14	1.41	0.27
Other Current Assets	20.58	19.19	138.42	31.78	60.26	19.9
Total Current Assets	744.68	744.77	620.04	323.28	346.71	219.27
Property, Plant & Equipment	294.89	258.56	112.26	112.43	65.51	62.05
Long-Term Investments	23.32	24.48	34.94	21.36	37.37	7.04
Other Intangible Assets	3.59	3.6	4.79	-	-	-
Long-Term Deferred Tax Assets	5.29	4.93	3.79	3.12	2.72	1.82
Other Long-Term Assets	177.31	167.33	174.69	15	135	-
Total Assets	1,249	1,204	950.51	475.2	587.31	290.18

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	56	89.14	29.3	13.38	98.46	66.22
Accrued Expenses	0.19	0.17	5.81	2.68	3.21	1.84
Short-Term Debt	-	-	-	-	28.69	18.2
Current Portion of Long-Term Debt	255.03	162.23	-	4.86	5.62	9.54
Current Income Taxes Payable	1.86	15.3	10.24	8.75	5.42	4.48
Other Current Liabilities	2.66	6.63	2.86	0.44	10.69	0.32
Total Current Liabilities	315.74	273.47	48.21	30.11	152.09	100.59
Long-Term Debt	14.08	15.4	19.4	16.82	17.47	25.76
Pension & Post-Retirement Benefits	3.03	2.87	2.11	1.2	1.06	-
Other Long-Term Liabilities	-	-	-	0	0.01	-0
Total Liabilities	332.86	291.74	69.72	48.13	170.62	126.35

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	344.49	344.49	344.49	175.23	175.23	100.06
Additional Paid-In Capital	-	-	431.86	177.97	177.97	30.07
Retained Earnings	-	-	120.07	86.9	66.2	55
Comprehensive Income & Other	571.75	567.43	-15.63	-13.02	-2.7	-21.31
Shareholders' Equity	916.23	911.92	880.79	427.08	416.69	163.82
Total Liabilities & Equity	1,249	1,204	950.51	475.2	587.31	290.18

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	269.11	177.63	19.4	21.68	51.77	53.51
Net Cash (Debt)	-265.37	-173.44	53.31	-17.37	-45.42	-51.75
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-1.45	-1.00	0.31	-0.20	-0.76	-1.02
Filing Date Shares Outstanding	431.8	189.44	172.24	87.61	87.61	50.03
Total Common Shares Outstanding	431.8	189.44	172.24	87.61	87.61	50.03
Working Capital	428.94	471.29	571.83	293.18	194.63	118.68
Book Value Per Share	2.12	4.81	5.11	4.87	4.76	3.27
Tangible Book Value	912.64	908.32	876	427.08	416.69	163.82
Tangible Book Value Per Share	2.11	4.79	5.09	4.87	4.76	3.27
Land	-	-	59.15	59.15	20.21	11.17
Buildings	-	-	28.94	18.32	18.51	18.51
Machinery	-	-	77.68	71.23	60.92	59.02
Construction In Progress	-	-	2.93	9.25	2.62	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error